Clinical Trial Update: Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study [Phase 4]

View source ↗

Summary

A Phase 4 proof-of-concept trial evaluating ixekizumab for refractory non-infectious uveitis across posterior, anterior, intermediate, and panuveitis manifestat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Uveitis
• Intermediate Uveitis
• Non-infectious Uveitis
• Panuveitis
• Posterior Uveitis
• Uveitis

Drugs mentioned

• Ixekizumab (ixekizumab)

Snippet

Sponsor: Massachusetts Eye Research and Surgery Institution | Conditions: Uveitis, Posterior, Uveitis, Anterior | Phase 4 | Status: UNKNOWN